ALFA Finder
17:15 IST
BSE
Board Meeting Date
Symbiotec Pharmalab Board Meeting Date
Symbiotec Pharmalab schedules a 5 November 2026 board meeting to consider unaudited quarterly and half-year results. No amounts are proposed.
Symbiotec Pharmalab Ltd
- Share price
- ₹1,611.00
- Market cap
- ₹10,352 Cr
- Revenue (annual)
- ₹869.1 Cr
- Net profit (annual)
- ₹109.9 Cr
- Promoter holding
- 33.28%
- FII holding
- 3.79%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 5Earnings Call 4Share Pledge 2Results Update 2Board Meeting Date 2Financial Results 1Capital Structure Change 1Business Update 1
Time
2 announcements with these filters
16:17 IST
BSE
Board Meeting Date
Symbiotec Pharmalab Board Meeting Date
Symbiotec Pharmalab Ltd scheduled a board meeting for September 21, 2026, to consider financial results for the quarter ended June 30, 2026.